Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

XTL BIOPHARMACEUTICALS LTD (XTLB)

$2.58 +0.00% NASDAQ: XTLB · 15-min delayed
  • NEW YORK, New York
  • Public · NASDAQ: XTLB
  • 2 employees
$7.2MMarket cap
2Employees
XTLBNASDAQ
2005IPO

About XTL BIOPHARMACEUTICALS LTD

XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Market cap
$7.2M
NASDAQ: XTLB
$2.58 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.06 $8.20

52-week range

Market cap
$7.2M
Shares outstanding
2.8M
Open
Day range
Prev close
Volume
IPO date
Sep 1, 2005

XTL Biopharmaceuticals Ltd (XTLB) Stock Price

  • Trading 69% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review XTL BIOPHARMACEUTICALS LTD.

Write a review
Newsroom

News about XTL BIOPHARMACEUTICALS LTD

News & sentiment via Polygon.io

FAQ

XTL Biopharmaceuticals Ltd: frequently asked questions

Is XTL Biopharmaceuticals Ltd an American company?

XTL Biopharmaceuticals Ltd is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is XTL Biopharmaceuticals Ltd headquartered?

XTL Biopharmaceuticals Ltd is headquartered in New York, New York, United States.

Is XTL Biopharmaceuticals Ltd publicly traded?

Yes — XTL Biopharmaceuticals Ltd is a publicly traded company. Its stock trades under the ticker symbol XTLB on the NASDAQ.

What does XTL Biopharmaceuticals Ltd do?

XTL Biopharmaceuticals Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →